Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Stadler

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
The Lancet. Haematology|April 4, 2026
Patient selection and treatment sequencing in RESMAIN - Author's replyRudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 12, 2021
René Stranzenbach, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 1, 2011
[Dermatology in an exciting decade]Thomas Luger, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2013
Preface. Molecular diagnostics in dermatologyRudolf Stadler, Alexander Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 1, 2019
Zum 65. Geburtstag von Dr. Michael ReuschThomas Luger, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 22, 2021
Combination of brentuximab-vedotin with skin-directed therapies extends the time to the next therapeutic line in patients with cutaneous T-cell lymphomaRené Stranzenbach, Rudolf Stadler
Experimental Dermatology|June 5, 2018
Molecular pathogenesis of cutaneous lymphomasRudolf Stadler, René Stranzenbach
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 23, 2022
Long term survival, time to next treatment and CD30 expression in patients with advanced CD30<sup>+</sup> cutaneous T-cell lymphoma treated with Brentuximab vedotin - A monocentric retrospective analysis of twelve patientsJanika Gosmann, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
[The countdown is ticking, Dresden calls!]Thomas Luger, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 30, 2011
[DDG KOMPAKT - continuing education for German speaking dermatology]Rudolf Stadler, Roland Kaufmann
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
The Lancet. Haematology|April 4, 2026
Patient selection and treatment sequencing in RESMAIN - Author's replyRudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 12, 2021
René Stranzenbach, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 1, 2011
[Dermatology in an exciting decade]Thomas Luger, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 1, 2013
Preface. Molecular diagnostics in dermatologyRudolf Stadler, Alexander Enk
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 1, 2019
Zum 65. Geburtstag von Dr. Michael ReuschThomas Luger, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 22, 2021
Combination of brentuximab-vedotin with skin-directed therapies extends the time to the next therapeutic line in patients with cutaneous T-cell lymphomaRené Stranzenbach, Rudolf Stadler
Experimental Dermatology|June 5, 2018
Molecular pathogenesis of cutaneous lymphomasRudolf Stadler, René Stranzenbach
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|March 23, 2022
Long term survival, time to next treatment and CD30 expression in patients with advanced CD30<sup>+</sup> cutaneous T-cell lymphoma treated with Brentuximab vedotin - A monocentric retrospective analysis of twelve patientsJanika Gosmann, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 9, 2009
[The countdown is ticking, Dresden calls!]Thomas Luger, Rudolf Stadler
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 30, 2011
[DDG KOMPAKT - continuing education for German speaking dermatology]Rudolf Stadler, Roland Kaufmann
Pageof 15